The prevalence of aminoglycoside-modifying enzyme and virulence genes among enterococci with high-level aminoglycoside resistance in Inner Mongolia, China  by Niu, Haiying et al.
MT
e
w
M
H
H
a
b
c
a
A
R
A
A
A
D
K
E
H
r
A
g
V
h
1
Bb r a z i l i a n j o u r n a l o f m i c r o b i o l o g y 4 7 (2 0 1 6) 691–696
ht tp : / /www.bjmicrobio l .com.br /
edical Microbiology
he prevalence  of  aminoglycoside-modifying
nzyme and  virulence  genes  among  enterococci
ith high-level  aminoglycoside  resistance  in Inner
ongolia, China
aiying Niua, Hui Yub, Tangping Hua, Gailin Tiana, Lixia Zhanga, Xiang Guoa,
ai  Huc,∗, Zhanli Wanga,∗
The First Afﬁliated Hospital, Baotou Medical College, Baotou, China
The Second Afﬁliated Hospital, Baotou Medical College, Baotou, China
Department of Pathophysiology, Baotou Medical College, Baotou, China
 r  t  i  c  l  e  i  n  f  o
rticle history:
eceived 12 January 2015
ccepted 22 December 2015
vailable online 20 April 2016
ssociate Editor: Ana Lúcia da Costa
arini
eywords:
nterococcus
igh-level aminoglycoside
esistance
minoglycoside-modifying enzyme
ene
irulence determinant
a  b  s  t  r  a  c  t
This study highlights the prevalence of aminoglycoside-modifying enzyme genes and vir-
ulence determinants among clinical enterococci with high-level aminoglycoside resistance
in  Inner Mongolia, China. Screening for high-level aminoglycoside resistance against 117
enterococcal clinical isolates was performed using the agar-screening method. Out of the
117  enterococcal isolates, 46 were selected for further detection and determination of the
distribution of aminoglycoside-modifying enzyme-encoding genes and virulence determi-
nants using polymerase chain reaction -based methods. Enterococcus faecium and Enterococcus
faecalis were identiﬁed as the species of greatest clinical importance. The aac(6′)-Ie-aph(2′′)-Ia
and ant(6′)-Ia genes were found to be the most common aminoglycoside-modifying enzyme
genes among high-level gentamicin resistance and high-level streptomycin resistance iso-
lates, respectively. Moreover, gelE was the most common virulence gene among high-level
aminoglycoside resistance isolates. Compared to Enterococcus faecium,  Enterococcus faecalis
harbored multiple virulence determinants. The results further indicated no correlation
between aminoglycoside-modifying enzyme gene proﬁles and the distribution of virulence
genes  among the enterococcal isolates with high-level gentamicin resistance or high-level
streptomycin resistance evaluated in our study.©  2016 Sociedade Brasileira de Microbiologia. Published by Elsevier Editora Ltda. This is
an  open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).∗ Corresponding authors.
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Introduction
Enterococci have emerged as an important source of hospital-
acquired infections, including those related to the surgical
site, respiratory tract, urinary tract, skin and soft tissue, and
bacteremia.1 Several studies have indicated increasing entero-
cocci resistance to a broad range of antimicrobial agents
via intrinsic and acquired mechanisms.2 High-level amino-
glycoside resistance (HLAR) has been recognized for several
decades. Gentamicin and streptomycin are the two main
aminoglycosides used in clinical practice. Recently, high-level
gentamicin resistance (HLGR) (MIC ≥500 g/ml) and high-
level streptomycin resistance (HLSR) (MIC ≥2000 g/ml) have
been reported worldwide.3–8 Clinical experience supports the
use of aminoglycosides along with cell-wall inhibitors for
treating serious enterococcal infections.9 However, high-level
resistance of clinical isolates of Enterococcus species to amino-
glycosides negates the synergism between cell-wall inhibitors
and aminoglycosides, making the treatment of serious ente-
rococcal infections difﬁcult.10
In general, enterococci are intrinsically resistant to clini-
cally achievable concentrations of aminoglycosides. However,
high-level resistance to aminoglycosides is primarily due
to acquisition of genes encoding aminoglycoside-modifying
enzymes (AMEs).11 Over past decades, a great deal of research
has been devoted to understanding the mechanisms behind
the high-level resistance of enterococci to aminoglycosides.
Until now, the following three classes of AMEs have been
identiﬁed: acetyltransferase (AAC), aminoglycoside phospho-
transferase (APH), and aminoglycoside nucleotidyltransferase
(ANT).12 The high-level resistance of enterococci to gentami-
cin is predominantly mediated by aac(6′)-Ie-aph(2′′)-Ia, which
encodes the bifunctional AME, AAC(6′)-APH(2′′).13 Ten years
ago, aph(2′′)-Ib, aph(2′′)-Ic, and aph(2′′)-Id were detected as
newer AME  genes conferring HLGR among enterococci.14–16
Furthermore, HLSR among enterococci is mediated by aph(3′)-
IIIa and ant(6′)-Ia encoding for APH(3′) and ANT(6′)-Ia,
respectively.3,11
Additionally, the rise of drug-resistant virulent strains of
enterococci is a serious problem in the treatment and control
of enterococcal infections. The pathogenicity of enterococci
is due to the presence of virulence determinants, such as
the Enterococcus faecalis (E. faecalis) antigen A (efaA), adhe-
sion of collagen from E. faecalis (ace) and products involved
in aggregation (agg), biosynthesis of an extracellular metal-
loendopeptidase (gelE), biosynthesis of cytolysin (cylA) and
immune evasion (esp).17 Previous research has shown that
clinical isolates of the Enterococcus species possess distinctive
patterns of virulence factors.18
The difﬁculty in treating enterococcal infections is asso-
ciated with determinants of virulence and antimicrobial
resistance. Therefore, accurate identiﬁcation of antibiotic
susceptibility patterns and virulence determinants is essen-
tial for choosing appropriate therapies and means of
infection control. The goal of the present study was to
investigate the occurrence of HLAR among enterococci in
Inner Mongolia, China. Additionally, the prevalence of six
AME  encoding genes, aac(6′)-Ie-aph(2′′)-Ia, aph(2′′)-Ib, aph(2′′)-
Ic, aph(2′′)-Id, aph(3′)-IIIa and ant(6′)-Ia, among enterococcal b i o l o g y 4 7 (2 0 1 6) 691–696
isolates collected from different specimen sources were
investigated. Moreover, the presence of virulence deter-
minants, such as efaA, ace, agg, gelE, cylA and esp, was
detected.
Experimental
Bacterial  strains  and  identiﬁcation
A total of 117 clinical isolates of enterococci were col-
lected from four hospitals in Inner Mongolia, China, between
May 2012 and May 2014. Duplicate isolates were excluded
from the study. Institutional ethical clearance was obtained.
The isolates were identiﬁed as enterococci by conven-
tional biochemical tests and VITEK 2 Compact (BioMérieux,
France). Identiﬁcations of E. faecalis, E. faecium and the
other strains were further conﬁrmed via PCR analysis using
ddlE. faecium, ddlE. faecalis and 16S rDNA genes, respectively.19
The isolates were then stored at −80 ◦C. Table 1 shows
the primers and the product sizes of all the genes
analyzed.19–23
Detection  of  HLAR  in  enterococci
Screening for HLAR was performed using the agar-screening
method according to the standards and interpretive crite-
ria described by the Clinical and Laboratory Standards
Institute (CLSI).24 Brieﬂy, brain heart infusion agar contain-
ing gentamicin (500 g/ml) and streptomycin (2000 g/ml)
was used. Plates were incubated for 24 h at 37 ◦C. The
aminoglycoside-susceptible strain E. faecalis ATCC 29212 and
the aminoglycoside-resistant strain E. fecalis ATCC 51299 were
utilized as controls for HLAR detection.
Ampliﬁcation  of  AMEs  and  virulence  genes
The total DNA template was extracted from enterococci
according to the instruction manuals of commercial DNA
extraction kits (Hangzhou BioSci Biotech Co., Ltd, China). A
PCR method was used to detect the presence of AME  and vir-
ulence genes.20–23 The primer couples, product sizes of the
genes and annealing temperatures are shown in Table 1. PCR
ampliﬁcation was performed using 1 g of the template DNA,
1 l of each primer (100 pmol), and 25 l of 2× PCR master
mix  (Hangzhou BioSci Biotech Co., Ltd, China) in a total vol-
ume  of 50 l. A C1000 Touch thermocycler (Bio-Rad, USA) was
also employed. PCR conditions were as follows: initial dena-
turation at 94 ◦C for 3 min; 35 cycles of denaturation at 94 ◦C
for 30 s, annealing for 30 s and elongation at 72 ◦C for 1 min,
and ﬁnal extension at 72 ◦C for 5 min. PCR products were ana-
lyzed by electrophoresis on 1% agarose gel following staining
with ethidium bromide.All statistical analyses were performed using Statistical
Package for Social Sciences (SPSS) software (version 11.5). A
p value <0.05 was considered statistically signiﬁcant.
b r a z i l i a n j o u r n a l o f m i c r o b i o l o g y 4 7 (2 0 1 6) 691–696 693
Table 1 – PCR protocols used in this study.
Gene Primers (5′–3′) Size (bp) Annealing temperature (◦C) Reference
ddlE.  faecium F-TTGAGGCAGACCAGATTGACG
R-TATGACAGCGACTCCGATTCC
658  54 Macovei and Zurek19
ddlE.  faecalis F-TCAAGTACAGTTAGTCTTTATTAG
R-ACGATTCAAAGCTAACTGAATCAGT
941  54 Macovei et al.19
16S rDNA F-GGATTAGATACCCTGGTAGTCC
R-TCGTTGCGGGACTTAACCCAAC
320  54 Macovei et al.19
aac(6′)-Ie-aph(2′′)-Ia F-CAGGAATTTATCGAAAATGGTAGAAAAG
R-CACAATCGACTAAAGAGTACCAATC
369  56 Emaneini et al.23
aph(2′′)-Ib F-CTTGGACGCTGAGATATATGAGCAC
R-GTTTGTAGCAATTCAGAAACACCCTT
867  56 Emaneini et al.23
aph(2′′)-Ic F-CCACAATGATAATGACTCAGTTCCC
R-CCACAGCTTCCGATAGCAAGAG
444  56 Emaneini et al.23
aph(2′′)-Id F-GTGGTTTTTACAGGAATGCCATC
R-CCCTCTTCATACCAATCCATATAACC
641  56 Emaneini et al.23
aph(3′)-IIIa F-GGCTAAAATGAGAATATCACCGG
R-CTTTAAAAAATCATACAGCTCGCG
523  56 Emaneini et al.23
ant(6′)-Ia F-ACTGGCTTAATCAATTTGGG
R-GCCTTTCCGCCACCTCACCG
577  56 Sepúlveda et al.22
cylA F-TGGATGATAGTGATAGGAAGT
R-TCTACAGTAAATCTTTCGTCA
517  54 Reviriego et al.21
gelE F-AGTTCATGTCTATTTTCTTCAC
R-CTTCATTATTTACACGTTTG
402  56 Duprè et al.20
esp F-TTACCAAGATGGTTCTGTAGGCAC
R-CCAAGTATACTTAGCATCTTTTGG
936  56 Duprè et al.20
ace F-AAAGTAGAATTAGATCCACAC
R-TCTATCACATTCGGTTGCG
320  56 Duprè et al.20
agg F-CCAGTAATCAGTCCAGAAACAACC
R-TAGCTTTTTTCATTCTTGTGTTTGTT
406  53 Duprè et al.20
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R-CTACTAACACGTCACGAATG
esults  and  discussion
esults
dentiﬁcation  of  Enterococcus  species
 total of 117 strains of enterococci were isolated from vari-
us clinical samples, including urine 48/117 (41.0%), wounds
8/117 (23.9%), bile 18/117 (15.4%), vaginal/semen swabs 6/117
5.1%), pus 6/117 (5.1%), blood 3/117 (2.6%), sputum 2/117
1.7%), and others 6/117 (5.1%). The predominant species
bserved in our study were E. faecium 63/117 (53.8%) and E.
aecalis 33/117 (28.2%). We  also detected E. avium 11/117 (9.4%),
. gallinarum 6/117 (5.1%), E. casseliﬂavus 3/117 (2.6%), and E.
urans 1/117 (0.9%).
etection  of  HLAR  in  enterococci
esistance rates were determined using the agar-screening
ethod. Among the 117 isolates tested, 50/117 (42.7%) were
LGR, and 32/117 (27.4%) were HLSR. A total of 12/117 (10.3%)
f our study isolates were both HLGR and HLSR. The high-
st resistance was observed among E. faecium, followed by E.
aecalis and E. avium.
CR  ampliﬁcation  of  AME  genes  in  gentamicin-resistant  or
treptomycin-resistant  isolates
f the 117 enterococcal isolates evaluated, 46 were selected
or further detection and determination of distributions of
ME  encoding genes (Table 2). Of 28 HLGR isolates (Table 2),499  56 Duprè et al.20
25 (89.3%) carried aac(6′)-Ie-aph(2′′)-Ia,  2 (7.1%) carried aph(2′′)-
Ic, 3 (10.7%) carried aph(2′′)-Id, and 7 (25.0%) carried aph(3′)-IIIa.
However, aph(2′′)-Ib was not detected among the isolates eval-
uated in this study. Some HLGR isolates carried multiple
AME genes. Two isolates (7.1%) carried aac(6′)-Ie-aph(2′′)-Ia and
aph(2′′)-Ic; 3 isolates (10.7%) carried aac(6′)-Ie-aph(2′′)-Ia and
aph(2′′)-Id; and 6 isolates (21.4%) carried aac(6′)-Ie-aph(2′′)-Ia
and aph(3′)-IIIa.
Similarly, of the 14 HLSR isolates identiﬁed in our study
(Table 3), 10 (71.4%) carried ant(6′)-Ia; 8 (57.1%) carried aph(3′)-
IIIa; and 7 (50.0%) carried both ant(6′)-Ia and aph(3′)-IIIa. PCR
analysis revealed the absence of resistance genes in suscepti-
ble isolates.
PCR  ampliﬁcation  of  AME  genes  in  both  gentamicin-  and
streptomycin-resistant  isolates
Table 4 shows the AME  gene proﬁles of both HLGR and HLSR
isolates. Of the 12 isolates analyzed, all 12 (100%) carried
aac(6′)-Ie-aph(2′′)-Ia; 9 (75.0%) carried ant(6′)-Ia; 7 (58.3%) car-
ried aph(3′)-IIIa; 2 (16.7%) carried aph(2′′)-Id; and 1 (8.3%) carried
aph(2′′)-Ic. Moreover, 11 isolates (91.7%) carried multiple (two
to four) AME  genes. Five isolates (41.7%) carried two genes;
4 isolates (33.3%) carried three genes; and 2 isolates (16.7%)
carried four genes.PCR  ampliﬁcation  of  virulence  genes  in  enterococci
Table 5 shows the presence of virulence genes among HLAR
isolates. Of the 30 isolates evaluated, 10 (33.3%) carried gelE; 8
(26.7%) carried efaA; 7 (23.3%) carried esp; 7 (23.3%) carried cylA;
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Table 2 – Distributions of aminoglycoside modifying enzyme-encoding genes in enterococci with high-level gentamicin
resistance. Some isolates carried multiple aminoglycoside modifying enzyme-encoding genes.
AME gene Distribution of high-level gentamicin resistance in enterococci (n = 28) Total no. (%) of isolates
E. faecium (n = 19) E.  faecalis (n = 7) E.  avium (n = 2)
aac(6′)-Ie-aph(2′′)-Ia 18  5 2 25 (89.3%)
aph(2′′)-Ib –  – – –
aph(2′′)-Ic – 2 – 2 (7.1%)
aph(2′′)-Id 2 – 1 3 (10.7%)
aph(3′)-IIIa 6 1 – 7 (25.0%)
aac(6′)-Ie-aph(2′′)-Ia + aph(2′′)-Ic – 2 – 2 (7.1%)
aac(6′)-Ie-aph(2′′)-Ia + aph(2′′)-Id 2 – 1 3 (10.7%)
aac(6′)-Ie-aph(2′′)-Ia + aph(3′)-IIIa 6 – – 6 (21.4%)
Table 3 – Distributions of aminoglycoside modifying enzyme-encoding genes in enterococci with high-level streptomycin
resistance. Some isolates carried multiple aminoglycoside modifying enzyme-encoding genes.
AME gene Distribution of high-level streptomycin resistance in enterococci (n = 14) Total no. (%) of isolates
E. faecium (n = 12) E.  faecalis (n = 2)
ant(6′)-Ia 9 1 10 (71.4%)
aph(3′)-IIIa 7 1 8 (57.1%)
ant(6′)-Ia + aph(3′)-IIIa 6  1 7 (50.0%)
Table 4 – Distributions of aminoglycoside modifying enzyme-encoding genes in enterococci with high-level resistance to
both streptomycin and gentamicin.
Enterococcal species Strain AME  gene proﬁle
E. faecium 6  aac(6′)-Ie-aph(2′′)-Ia
13 aac(6′)-Ie-aph(2′′)-Ia + ant(6′)-Ia
15 aac(6′)-Ie-aph(2′′)-Ia + aph(2′′)-Id
20 aac(6′)-Ie-aph(2′′)-Ia + ant(6′)-Ia
21 aac(6′)-Ie-aph(2′′)-Ia + aph(3′)-IIIa + ant(6′)-Ia
29 aac(6′)-Ie-aph(2′′)-Ia + ant(6′)-Ia
30 aac(6′)-Ie-aph(2′′)-Ia + aph(3′)-IIIa + ant(6′)-Ia
34 aac(6′)-Ie-aph(2′′)-Ia + aph(3′)-IIIa + ant(6′)-Ia
43 aac(6′)-Ie-aph(2′′)-Ia + aph(3′)-IIIa
49 aac(6′)-Ie-aph(2′′)-Ia + aph(3′)-IIIa + ant(6′)-Ia
51 aac(6′)-Ie-aph(2′′)-Ia + aph(2′′)-Id + aph(3′)-IIIa + ant(6′)-Ia
E. faecalis 44  aac(6′)-Ie-aph(2′′)-Ia + aph(2′′)-Ic + aph(3′)-IIIa + ant(6′)-Ia
Table 5 – Distributions of virulence genes in enterococci with high-level aminoglycoside resistance.
Virulence gene Distribution of high-level aminoglycoside resistance in enterococci (n = 30) Total no. (%) of isolates
E. faecium (n = 20) E. faecalis (n = 8) E. avium (n = 2)
gelE 4 6 0 10 (33.3%)
esp 2 4 1 7 (23.3%)
cylA 3 4 0 7 (23.3%)
ace 0 1 0 1 (3.3%)
agg 0 0 
efaA 0 8 
and 1 (3.3%) carried ace.  The agg gene was not detected in any
of isolates. Moreover, AME  gene proﬁles and distributions of
virulence determinants were compared among HLGR or HLSR
isolates, and no signiﬁcant correlations were found.
DiscussionEnterococci have long been considered one of the most
common sources of nosocomial pathogens. The rise of drug-
resistant virulent strains of enterococci presents a serious0 0 (0%)
0 8 (26.7%)
problem with regard to controlling enterococcal infections.
Aminoglycoside antibiotics provide efﬁcient therapies for
severe enterococcal infections. However, the introduction
of two aminoglycoside antibiotics (gentamicin and strep-
tomycin) was followed by the emergence of resistance in
enterococci.
To date, several Enterococcus species have been reported,
including E. faecium, E. faecalis, E. avium,  E. durans, E. galli-
narum, E. casseliﬂavus, E. rafﬁnosus, E. mundtii, E. malodoratus,
and E. hirae.25 Similar to previous ﬁndings in China,26
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. faecium and E. faecalis comprise the predominant condition-
lly pathogenic bacteria in the present report. Additionally,
ur antibiotic susceptibility test results identiﬁed 42.7% HLGR
nd 27.4% HLSR clinical isolates, similar to other reports.9
oreover, in agreement with previous studies,9 HLGR was
ound to be more  common than HLSR in enterococci species.
HLAR is primarily due to the presence of AME  genes.
LGR has reportedly been associated with aac(6′)-Ie-aph(2′′)-
a, aph(2′′)-Ib, aph(2′′)-Ic, aph(2′′)-Id, and aph(3′)-IIIa. However,
LSR is mainly mediated by aph(3′)-IIIa and ant(6′)-Ia.3,27 To
nderstand HLAR in enterococci in our region, we investi-
ated the distribution of AME  genes among enterococci. As
eported in other studies,22,27 our analyses identiﬁed aac(6′)-
e-aph(2′′)-Ia and ant(6′)-Ia as the most common AME genes
mong HLGR and HLSR isolates, respectively. It is noteworthy
hat some HLAR isolates did not harbor any AME genes. We
resume that this phenomenon may be due to the action of
ther resistance mechanisms. On the other hand, we detected
ome isolates that co-harbored two, three, or four AME genes
imultaneously, consistent with previous studies.28
The distributions of virulence genes among enterococci
ere further investigated. As reported in other studies,29 gelE
as identiﬁed as the most frequent virulence factor and was
ore  common in E. faecalis than E. faecium. Esp, cylA and ace
enes were found in 23.3%, 23.3% and 3.3% of the HLAR iso-
ates, respectively. Recently, Shariﬁ et al. reported that 52.1%
f enterococci from hospitalized patients with urinary tract
nfections tested positive for the esp gene,30 this value is
igher than that determined by the present study. Like previ-
us reports, our ﬁndings found that all HLAR E. faecalis isolates
arbored efaA.31 However, agg was not detected in any of
he enterococci isolates studied herein. Similar to previous
tudies,32 E. faecium and E. faecalis strains showed signiﬁcantly
ifferent patterns with regard to the incidence of virulence
eterminants. Contrary to E. faecium, E. faecalis harbored mul-
iple virulence genes.
onclusions
his study indicates that enterococci recovered from clini-
al samples in Inner Mongolia, China, contain a variety of
ME genes and virulence determinants. The aac(6′)-Ie-aph(2′′)-
a and ant(6′)-Ia genes were the most common AME genes
mong HLGR and HLSR enterococci, respectively, and gelE was
he most frequent virulence determinant.
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